Dr. Ahmad Nadeem Rafi, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1660 W C Pl, Russellville, AR 72801 Phone: 479-967-7770 Fax: 479-967-7772 |
Dr. Stanley E. Gately, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1808 W Main St, Russellville, AR 72801 Phone: 479-968-2841 |
Dr. Virgil R. Massey Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1808 W Main St, Russellville, AR 72801 Phone: 479-968-2841 |
Dr. Thomas C. Williams, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1808 W Main St, Russellville, AR 72801 Phone: 479-968-2841 |
News Archive
"Teenage pregnancies are on the rise in Guatemala, along with the drop-out rate in schools, family breakdown and many other related social ills," Inter Press Service reports, adding that the "impoverished Central American country of 14 million people has an adolescent (under-20) birth rate of 114 per 1,000 women in rural areas, according to the National Mother and Child Health Survey for 2008-2009."
The explosion and fire on a BP-licensed oil platform in the Gulf of Mexico in April 2010 had huge environmental and economic effects, with millions of gallons of oil leaking into the water for more than five months. It also had significant psychological impact on people living in coastal communities, even in those areas that did not have direct oil exposure, according to researchers at the University of Maryland School of Medicine who worked in collaboration with the University of Florida, Gainesville.
The use of diagnostic imaging has nearly tripled since the mid-1990s, according to a new study, raising questions about whether the benefits outweigh the risks of increased radiation exposure.
Roche has announced that it has submitted a combined filing to the European health authorities (the European Medicines Agency) for three new indications to extend the label for MabThera to use as a first-line biologic therapy for patients with rheumatoid arthritis (RA).
Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system, today reported its financial results for the three and six months ended June 30, 2010.
› Verified 6 days ago